Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Eli Lilly's Popular Weight Loss/Diabetes Drug ... - AOL

   www.aol.com/eli-lillys-popular-weight-loss...

   Thursday, Eli Lilly and Company (NYSE:LLY) released topline results from the SUMMIT phase 3 clinical trial evaluating the safety and efficacy of tirzepatide injection (5 mg, 10 mg, or 15 mg) in ...

3. Eli Lilly, Boehringer Share Jardiance Data In Heart ... - AOL

   www.aol.com/news/eli-lilly-boehringer-share...

   At the 26-month mark, 13.8% of Jardiance patients d. Eli Lilly And Co (NYSE: LLY) and Boehringer Ingelheim have rolled out full results of EMPEROR-Preserved phase 3 trial of Jardiance ...

4. Empagliflozin - Wikipedia

   en.wikipedia.org/wiki/Empagliflozin

   Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar loss in urine. [ 2] Empagliflozin was approved for medical use in the United States and in the European Union in 2014. [ 11][ 22][ 23] It is on the World Health Organization's List of Essential Medicines. [ 24]

5. US FDA says all doses of Lilly's weight-loss and diabetes ...

   www.aol.com/news/us-fda-says-doses-lillys...

   August 2, 2024 at 6:03 PM. By Bhanvi Satija and Sneha S K. (Reuters) -All doses of Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are now available, the U.S. Food and Drug ...

6. Eli Lilly's Obesity Drug Shows a Heart Benefit. Is It ... - AOL

   www.aol.com/finance/eli-lillys-obesity-drug...

   Of course, Eli Lilly is not a one-drug company. Management expects total sales to climb from $34.1 billion in 2023 to between $42.4 billion and $43.6 billion this year.

7. Eli Lilly launches website to help patients get weight loss drugs

   www.aol.com/news/eli-lilly-launches-website-help...

   Lilly said the online platform for weight loss drugs is only intended for people who currently meet the criteria for a weight loss drug in the U.S.: People with a BMI of at least 30 or a BMI of at ...

8. Lilly says weight loss drug cuts heart failure risk by ... - AOL

   www.aol.com/news/lilly-says-weight-loss-drug...

   The drug led to 15.7% weight loss in the combined population of people with and without type 2 diabetes, compared with 2.2% for the placebo, Lilly said. For the non-diabetes patients, weight loss ...

9. Eli Lilly’s CFO explains why the company’s newest ... - AOL

   www.aol.com/finance/eli-lilly-cfo-explains-why...

   Lilly (No. 142 on the Fortune 500), the Indianapolis-based pharmaceutical company, announced on Nov. 8 that Zepbound, a weight-loss drug, was approved by the U.S. Food and Drug Administration. The ...